What’s going on today?
Do you love the Afternoon Docket? Think we could do some things better? Take our brief survey and let us know what you’d like to see.
|
REUTERS/Evelyn Hockstein/File Photo
|
The U.S. Supreme Court‘s ruling today keeping mifepristone on the market with no new restrictions ends one chapter of the legal fight over the abortion drug, but efforts by abortion opponents to restrict its use may not be over, Brendan Pierson reports.
In rejecting a lawsuit by anti-abortion medical groups and doctors, the Supreme Court did not rule on their claim that the FDA acted improperly when it eased restrictions on mifepristone. Instead, the court found they had not shown that they had suffered the kind of harm that would allow them to bring a lawsuit.
Normally, that would be the end of the case, but last November U.S. District Judge Matthew Kacsmaryk allowed three Republican-led states that ban abortion to join the case as plaintiffs. Now, those states can try to go forward on their own. Read more about what’s next.
More from SCOTUS today:
More top news:
|